Yarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate
Yarrow Bioscience (NASDAQ:YARW) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(0.22) by 872.73 percent.
Read original at benzingaStocks · News reference
BTIG Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $58
BTIG analyst Julian Harrison initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $58.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 3, 2026, 10:42 AM
- Checked
- Aug 3, 2026, 10:42 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
Wall Street analysts changed outlook on top names. For full changes, see our analyst ratings page. Analysts have mixed opinions on SCHW stock.
Read original at benzingaTD Cowen Initiates Coverage On Yarrow Bioscience with Buy Rating
TD Cowen analyst Stacy Ku initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating.
Read original at benzinga